The Epigenetic Effects of Butyrate: Potential Therapeutic Implications for Clinical Practice

Overview

Journal Clin Epigenetics

Publisher Biomed Central

Specialty Genetics

Date 2012 Mar 15

PMID 22414433

Citations 161

Authors

Roberto Berni Canani

Margherita Di Costanzo

Ludovica Leone

Affiliations

Soon will be listed here.

Abstract

Butyrate is a short chain fatty acid derived from the microbial fermentation of dietary fibers in the colon. In the last decade, multiple beneficial effects of butyrate at intestinal and extraintestinal level have been demonstrated. The mechanisms of action of butyrate are different and many of these involve an epigenetic regulation of gene expression through the inhibition of histone deacetylase. There is a growing interest in butyrate because its impact on epigenetic mechanisms will lead to more specific and efficacious therapeutic strategies for the prevention and treatment of different diseases ranging from genetic/metabolic conditions to neurological degenerative disorders. This review is focused on recent data regarding the epigenetic effects of butyrate with potential clinical implications in human medicine.

Citing Articles

Role of epigenetics in corneal health and disease.

Sood S, Tiwari A, Sangwan J, Vohra M, Sinha N, Tripathi R Prog Retin Eye Res. 2024; 104():101318.

PMID: 39547455 PMC: 11710990. DOI: 10.1016/j.preteyeres.2024.101318.

Bioactive Compounds and Their Chondroprotective Effects for Osteoarthritis Amelioration: A Focus on Nanotherapeutic Strategies, Epigenetic Modifications, and Gut Microbiota.

Hridayanka K, Duttaroy A, Basak S Nutrients. 2024; 16(21).

PMID: 39519419 PMC: 11547880. DOI: 10.3390/nu16213587.

Multi-View Integrative Approach For Imputing Short-Chain Fatty Acids and Identifying Key factors predicting Blood SCFA.

Liu A, Tian B, Qiu C, Su K, Jiang L, Zhao C bioRxiv. 2024; .

PMID: 39386638 PMC: 11463355. DOI: 10.1101/2024.09.25.614767.

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.

Gharib E, Robichaud G Int J Mol Sci. 2024; 25(17).

PMID: 39273409 PMC: 11395697. DOI: 10.3390/ijms25179463.

Establishing a novel inflammatory bowel disease prediction model based on gene markers identified from single nucleotide variants of the intestinal microbiota.

Jiang S, Chen D, Ma C, Liu H, Huang S, Zhang J Imeta. 2024; 1(3):e40.

PMID: 38868717 PMC: 10989788. DOI: 10.1002/imt2.40.

References

Fernandez-Morera J, Calvanese V, Rodriguez-Rodero S, Menendez-Torre E, Fraga M . Epigenetic regulation of the immune system in health and disease. Tissue Antigens. 2010; 76(6):431-9. DOI: 10.1111/j.1399-0039.2010.01587.x. View

Schauber J, Iffland K, Frisch S, Kudlich T, Schmausser B, Eck M . Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. Mol Immunol. 2004; 41(9):847-54. DOI: 10.1016/j.molimm.2004.05.005. View

Ma X, Ezzeldin H, Diasio R . Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs. 2009; 69(14):1911-34. DOI: 10.2165/11315680-000000000-00000. View

Bonnet D, Dick J . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997; 3(7):730-7. DOI: 10.1038/nm0797-730. View

Stefanko D, Barrett R, Ly A, Reolon G, Wood M . Modulation of long-term memory for object recognition via HDAC inhibition. Proc Natl Acad Sci U S A. 2009; 106(23):9447-52. PMC: 2695069. DOI: 10.1073/pnas.0903964106. View

Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, Miene C . Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res. 2009; 682(1):39-53. DOI: 10.1016/j.mrrev.2009.04.001. View

Pool-Zobel B, Veeriah S, Bohmer F . Modulation of xenobiotic metabolising enzymes by anticarcinogens -- focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res. 2005; 591(1-2):74-92. DOI: 10.1016/j.mrfmmm.2005.04.020. View

Berni Canani R, Di Costanzo M, Leone L, Pedata M, Meli R, Calignano A . Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011; 17(12):1519-28. PMC: 3070119. DOI: 10.3748/wjg.v17.i12.1519. View

Hallert C, Bjorck I, Nyman M, Pousette A, Granno C, Svensson H . Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis. 2003; 9(2):116-21. DOI: 10.1097/00054725-200303000-00005. View

10.

Perrine S, Ginder G, Faller D, Dover G, Ikuta T, Witkowska H . A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med. 1993; 328(2):81-6. DOI: 10.1056/NEJM199301143280202. View

11.

McKay J, Mathers J . Diet induced epigenetic changes and their implications for health. Acta Physiol (Oxf). 2011; 202(2):103-18. DOI: 10.1111/j.1748-1716.2011.02278.x. View

12.

Reid T, Valone F, LiPera W, Irwin D, Paroly W, Natale R . Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer. Lung Cancer. 2004; 45(3):381-6. DOI: 10.1016/j.lungcan.2004.03.002. View

13.

Meddings J . The significance of the gut barrier in disease. Gut. 2008; 57(4):438-40. DOI: 10.1136/gut.2007.143172. View

14.

Bolden J, Peart M, Johnstone R . Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006; 5(9):769-84. DOI: 10.1038/nrd2133. View

15.

Berni Canani R, Di Costanzo M, Leone L, Bedogni G, Brambilla P, Cianfarani S . Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev. 2011; 24(2):198-205. DOI: 10.1017/S0954422411000102. View

16.

Dashwood R, Ho E . Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol. 2007; 17(5):363-9. PMC: 2737738. DOI: 10.1016/j.semcancer.2007.04.001. View

17.

Hase K, Murakami M, Iimura M, Cole S, Horibe Y, Ohtake T . Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology. 2004; 125(6):1613-25. DOI: 10.1053/j.gastro.2003.08.028. View

18.

Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S, Clarke M . Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100(7):3983-8. PMC: 153034. DOI: 10.1073/pnas.0530291100. View

19.

Vernia P, Annese V, Bresci G, DAlbasio G, DInca R, Giaccari S . Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest. 2003; 33(3):244-8. DOI: 10.1046/j.1365-2362.2003.01130.x. View

20.

Kim H, Leeds P, Chuang D . The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem. 2009; 110(4):1226-40. PMC: 2726719. DOI: 10.1111/j.1471-4159.2009.06212.x. View